Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

Completed · Not applicable · Has a placebo group

Conditions studied: Mild Cognitive Impairment, Alzheimer Disease, Type2 Diabetes

In brief

To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).

Key facts

Study ID

NCT03933696

Run by

Icahn School of Medicine at Mount Sinai

People needed

25

Starts

2019-01-02

Expected to finish

2025-05-31

Last updated by the study team

2026-07-13

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild cognitive impairment
• Mild Alzheimer's Disease
• Sleep Disturbance
• Live at home

You may not qualify if…

• Blindness
• insulin-dependent diabetes patients
• macular degeneration
• severe sleep apnea

Where it is running

• Rutgers University — New Brunswick, New Jersey, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.